Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Sample Articles from IJPC

About IJPC

The International Journal of Pharmaceutical Compounding (IJPC) is a bi-monthly scientific and professional journal emphasizing quality pharmaceutical compounding.

The Journal is available in both printed and electronic format with digital versions of individual articles and complete issues delivered in Adobe® Acrobat PDF format.

Search the Journal by issue, topic or keyword.

Request a free copy of the Journal

Material printed in IJPC is covered by copyright. All rights reserved. See the Reprints and Permissions Page for more information.

Request a copy of
"Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery"

Read Abstract

A link to this sample article download page may be freely posted on web sites, chat rooms, and message boards provided that attribution to IJPC is included. The URL for this item is http://ijpc.com/​Sample/​Article.cfm?SID=90

The sample document may NOT be electronically posted, published, or redistributed without the prior permission of IJPC.

Complete the following to have a download link emailed to you.

Name:
Email:
Organization:
Used For:
 
Related Articles
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery
Heim Bob
Jan/Feb 2006
Pg. 14-18

View Sample
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Frankum James
, Ramsay Dale, Das Nandita G, Das Sudip K
Mar/Apr 2004
Pg. 101-105

Compounding for Athletes: Common Questions about Sports Medicine
Allen Loyd V Jr
Jul/Aug 1999
Pg. 285-287

Basics of Compounding for Iontophoresis, Part II
Allen Loyd V Jr
Jul/Aug 2002
Pg. 288-292

Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drop
Allen Loyd V Jr
May/Jun 1999
Pg. 225

Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Goodwin Donald A
, Fuhram L Clifton
Nov/Dec 1999
Pg. 496-500

Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drops
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 185

Compounding for Athletes: Successful Sports Compounds
Hudson Sonora
Sep/Oct 1999
Pg. 382-383

Case Reports: Iontophoresis and Phonophoresis for Treating Epicondylitis
Miller DeWayne
, Vann Pat, Hudson Sonora
Nov/Dec 1999
Pg. 441-442

Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Jul/Aug 2008
Pg. 295-304

Compounding for Sports Medicine
Vail Jane
Nov/Dec 2004
Pg. 443-447

Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application
Polonini Hudson
, de Oliveira Ferreira Anderson, Dijkers Eli
Sep/Oct 2021
Pg. 422-426

The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K
Jan/Feb 2013
Pg. 74-85

View Sample
Compounding for Athletes: A Primer for Rookies
Letendre Mark
, Hudson Sonora
Mar/Apr 1999
Pg. 104-106

Quantification of Total Dexamethasone Phosphate Delivery by Iontophoresis
Anderson Carter R
, Boeh Stephen D, Morris Russell L, Sembrowich Walter L, Panus Peter C
Mar/Apr 2003
Pg. 155-159

Basics of Compounding: Iontophoresis, Part 1
Allen Loyd V Jr
May/Jun 2002
Pg. 194-197

Transdermal Gel in the Treatment of Postoperative Pain
Alexander Kayla
, Wynn Tom
May/Jun 2007
Pg. 181-184

Managing Pain with Transdermal Ketoprofen
Williams KaCee D
May/Jun 2010
Pg. 204-206

Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Allen Loyd V Jr
Mar/Apr 2011
Pg. 157

Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Boddu Sai HS
, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
May/Jun 2014
Pg. 256-261

Blue Goo Anti-Itch Gel
Allen Loyd V Jr
Mar/Apr 2016
Pg. 144

Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Allen Loyd V Jr
Mar/Apr 2024
Pg. 131

Sport Body Cooler
Allen Loyd V Jr
May/Jun 2011
Pg. 247

Utilization of Compounded Medications in an Oral Medicine Practice
Stock Shannon
, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Mar/Apr 2016
Pg. 155-158

Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy
, Williams LaVonn
Jul/Aug 2022
Pg. 293-296

Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream)
Allen Loyd V Jr
Jul/Aug 2020
Pg. 320

Ferric Pyrophosphate 50-mg/mL Solution for Iontophoresis
Allen Loyd V Jr
Sep/Oct 2009
Pg. 432

Transdermal Delivery of Nisoldipine: Refinement of Vehicles
El Maghraby Gamal M
, Ahmed Amal A, Osman Mohamed A
Mar/Apr 2015
Pg. 152-160

Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Jan/Feb 2019
Pg. 52

Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2019
Pg. 53

Development and Evaluation of an Anti-aging Cosmetic Formulation Exploring Antioxidant Potential of Vitis vinifera L.
Carneiro Jaqueline
, Marques Gonçalves Melissa, Vicente Pereira Airton
Nov/Dec 2020
Pg. 515-518

Compounding for Athletes: Tips for Making the Team
Hudson Sonora
May/Jun 1999
Pg. 206-208

Phonophoresis with Hydrocortisone 10% in a Highly Viscous Complant Base
Bailey Keith A
Mar/Apr 1998
Pg. 110

Evaluating Transdermal Medication Forms for Veterinary Patients, Part 3: Methimazole
Davidson Gigi S
Jul/Aug 2001
Pg. 282-283

Hydrocortisone 10% Phonophoresis Gel
Allen Loyd V Jr
Nov/Dec 2001
Pg. 454

Basics of Compounding: Phonophoresis
Allen Loyd V Jr
Sep/Oct 2002
Pg. 362-365

Betamethasone Dipropionate 0.05% Gel for Phonophoresis
Allen Loyd V Jr
Sep/Oct 2002
Pg. 364

Piroxicam 0.5% Gel for Phonophoresis
Allen Loyd V Jr
Sep/Oct 2002
Pg. 364

Dexamethasone Sodium 0.4% Gel for Phonophoresis
Allen Loyd V Jr
Sep/Oct 2002
Pg. 364

Fluocinonide 0.1% Gel for Phonophoresis
Allen Loyd V Jr
Sep/Oct 2002
Pg. 364

Ketoprofen 2% Gel for Phonophoresis
Allen Loyd V Jr
Sep/Oct 2002
Pg. 364

Naproxen 5% Gel for Phonophoresis
Allen Loyd V Jr
Sep/Oct 2002
Pg. 364

Sodium Salicylate 10% Gel for Phonophoresis
Allen Loyd V Jr
Sep/Oct 2002
Pg. 364

Hydrocortisone 10% Gel for Phonophoresis
Allen Loyd V Jr
Sep/Oct 2002
Pg. 364

The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel
Arnold John J
, Asbill Scott
Nov/Dec 2009
Pg. 569-571

Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William
, Helms Scott R
Sep/Oct 2008
Pg. 392-397

Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream
Allen Loyd V Jr
Nov/Dec 2008
Pg. 546

Ionic Hydration Solution for Anti-Cancer Therapy
Allen Loyd V Jr
Mar/Apr 2009
Pg. 156

Transdermal Dosing Considerations for Veterinarians
Williams KaCee D
Sep/Oct 2009
Pg. 358-360

In Vitro Transdermal Diffusion of Zileuton from a Topical Gel
Bigeleisen Paul E
Sep/Oct 2006
Pg. 392-395

Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety
Fields Shannon W
Nov/Dec 2006
Pg. 418

To Compound or Not to Compound: A Veterinary Transdermal Discussion
Eichstadt Lauren R
, Davidson Gigi S
Sep/Oct 2014
Pg. 366-369

Compounding Transdermal Medication for Feline Patients
Eichstadt Lauren R
Jul/Aug 2016
Pg. 271-274

Feline Transdermal Formulation Considerations
Forsythe Lauren Eichstadt
Nov/Dec 2017
Pg. 446-452

Extemporaneous Preparation of Sertraline Cream for Transdermal Administration
Wynn Tom
, Goetsch Daniel
May/Jun 2011
Pg. 200-203

Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin
Rudner Shara
, Browne Paul
Nov/Dec 2010
Pg. 488-491

The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs
Bramwell Bethany L
, Williams LaVonn A
Jan/Feb 2012
Pg. 62-63

Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy
Griffee Chris
, Delano Amy
Mar/Apr 2012
Pg. 110-114

Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Woodall Rachel
, Arnold John J, McKay Doug, Abill C Scott
May/Jun 2013
Pg. 247-253

Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle
Polonini Hudson
, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
Jan/Feb 2019
Pg. 65-69

Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig
, Jean Linda, Carvalho Maria, Robson-Laws Michael
Nov/Dec 2022
Pg. 468-472

Evaluation of Compounded Transdermal Analgesic Formulations Using the Franz Finite Dose Model
Baneshi Marzieh
, Tyagi Deependra, Panneerselvam Ezilrani, MacKenzie Graham, Coleman Johngary, Zhang Shine X
Sep/Oct 2023
Pg. 424-430

Pathophysiology and Management of Onychomycosis and Novel Approaches for Effective Transdermal Applications
Dharmian Jose Prakash
, Sathiyaseelan Iraniammal, Renganathan Akshaya, Mubees Alamaan Mohamed, Naser Mohammed Yasin Abdul, Ramkrishnan Prakash, Arumugam Somasundaram
Nov/Dec 2023
Pg. 494-502

Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats
Eichstadt Lauren R
, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
May/Jun 2017
Pg. 242-246

Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time
Heustess Allie
, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott
Mar/Apr 2015
Pg. 167-173

Tranilast 0.8% for Iontophoresis
Allen Loyd V Jr
Mar/Apr 2002
Pg. 133

Iontophoresis Solutions for Arthritis
Allen Loyd V Jr
Nov/Dec 1999
Pg. 472

Acetic Acid 5% Iontophoresis Solution
Allen Loyd V Jr
Nov/Dec 2001
Pg. 450

Dexamethasone, Lidocaine, and Verapamil Iontophoresis Solutions for Peyronie's Disease
Allen Loyd V Jr
Nov/Dec 2001
Pg. 452

Dexamethasone and Lidocaine Solution for Iontophoresis
Allen Loyd V Jr
Nov/Dec 1997
Pg. 410

Estriol Solution for Iontophoresis for Acne Scars
Allen Loyd V Jr
Nov/Dec 1997
Pg. 411

Ketorolac Solution for Iontophoresis
Allen Loyd V Jr
Nov/Dec 1997
Pg. 415

Lidocaine HCl 2% Solution for Iontophoresis
Allen Loyd V Jr
Nov/Dec 1997
Pg. 416

Iontophoresis Devices: Clinical Applications for Topical Delivery
Panus Peter
, Banga Ajay K
Nov/Dec 1997
Pg. 420-424

Case Report: Iontophoresis with Lidocaine and Dexamethasone for Treating Rotator Cuff Injury in a Hockey Player
Preckshot John
Nov/Dec 1999
Pg. 441

Lidocaine HCl 4% Solution for Iontophoresis
Allen Loyd V Jr
Jul/Aug 2002
Pg. 290

Dexamethasone 4-mg/mL Solution for Iontophoresis
Allen Loyd V Jr
Jul/Aug 2002
Pg. 290

Acetic Acid 2% Solution for Iontophoresis
Allen Loyd V Jr
Jul/Aug 2002
Pg. 290

Ketorolac 6-mg/mL Solution for Iontophoresis
Allen Loyd V Jr
Jul/Aug 2002
Pg. 291

Dexamethasone Sodium Phosphate 1-mg/mL for Iontophoresis
Allen Loyd V Jr
Mar/Apr 1998
Pg. 147

Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh
Vail Jane
Jan/Feb 2006
Pg. 9-11

Hydrocortisone 0.5% Ethanolic Gel
Allen Loyd V Jr
Sep/Oct 2007
Pg. 423

Cyclosporine Topical Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 64

Update on Managing Neuropathic Pain
McNulty Jack P
, Muller George
May/Jun 2009
Pg. 182-190

Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 540

Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 541

Flurandrenolide Topical Film
Allen Loyd V Jr
Sep/Oct 2008
Pg. 451

Case Reports: Compounding to Relieve Arthritis Pain
Marshall Robert
, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
Nov/Dec 2008
Pg. 498-504

Indomethacin 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 543

Ketorolac Tromethamine 2% Topical Gel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 544

Trigger Point Gel
Allen Loyd V Jr
Jan/Feb 2010
Pg. 75

Compounded Pain Formulations: What is the Evidence?
Asbill Scott
, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014
Pg. 278-286

Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2015
Pg. 295-300

Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment
Allen Loyd V Jr
Jan/Feb 2016
Pg. 51

Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Rabi Joseph
Mar/Apr 2016
Pg. 107-113

Betamethasone 0.1% and Neomycin 0.6% Gel-Cream
Allen Loyd V Jr
Jul/Aug 2017
Pg. 312

Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox)
Ip Kendice
, Carvalho Maria, Shan Ashley, Banov Daniel
Jul/Aug 2017
Pg. 322-329

Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Trimble John
, Light Bob
May/Jun 2016
Pg. 250-256

Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Jones Nat
, Carvalho Maria, Branvold-Herr Andrea
May/Jun 2017
Pg. 205-211

Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
Sep/Oct 2013
Pg. 380-383

A Concise Discussion of Headache Types, Part 1
Williams LaVonn A
Mar/Apr 2012
Pg. 125-132

A Concise Discussion of Headache Types, Part 3: Migraine
Williams LaVonn A
, Allen Loyd V Jr
Jul/Aug 2012
Pg. 270-274

Celecoxib 10-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 242

Triamcinolone 0.1% Lotion
Allen Loyd V Jr
May/Jun 2011
Pg. 249

Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
Jul/Aug 2011
Pg. 308-315

Methylprednisolone 4-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2011
Pg. 340

Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream
Allen Loyd V Jr
Jul/Aug 2023
Pg. 319

Cyclosporine Topical Gel Formulation
Allen Loyd V Jr
Jul/Aug 2023
Pg. 320-321

Compounded Pain Formulations: What is the Evidence?
Asbill Scott
, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024
Pg. 100-109

Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2024
Pg. 111-116

In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%)
Kohan Hamed Gilzad
, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Mar/Apr 2021
Pg. 146-155

Diclofenac Sodium 1%-15% Topical Gel
Allen Loyd V Jr
Jan/Feb 2022
Pg. 55

Mometasone Furoate 0.1% Lotion
Allen Loyd V Jr
Jan/Feb 2022
Pg. 57

Dexamethasone 2 mg/g Topical Paste, Veterinary
Allen Loyd V Jr
Mar/Apr 2019
Pg. 149

Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Mar/Apr 2019
Pg. 150

The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2
Williams LaVonn A
Jan/Feb 2019
Pg. 14-21

Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 490

Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2021
Pg. 46

Dexamethasone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2020
Pg. 225

Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules
Allen Loyd V Jr
May/Jun 2020
Pg. 227

Prednisolone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2020
Pg. 229

Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jul/Aug 2020
Pg. 315

Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
Nov/Dec 2016
Pg. 495-500

Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel
Allen Loyd V Jr
Nov/Dec 2016
Pg. 507

Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2010
Pg. 74

A Patient's Guide to Transdermal Treatment of Pain
Fields Shannon W
Sep/Oct 2005
Pg. 354

Transdermal Methimazole in the Treatment of 16 Cats with Hyperthyroidism
Wingate Gary
Sep/Oct 2002
Pg. 344-345

In Vitro Transdermal Delivery and Stability of Liposome-Encapsulated Prostaglandin E1
Foldvari Marianna
, Oguejifor Cosmas
Mar/Apr 1999
Pg. 160-163

Transdermal Gels in the Treatment of Diabetic Neuropathy
Hodges Caroline J
, Jones Thomas H, Willoughby David L
Mar/Apr 2000
Pg. 91-93

Evaluating Transdermal Medication Forms for Veterinary Patients, Part 1
Davidson Gigi S
Mar/Apr 2001
Pg. 95-96

Transdermal Nifedipine for Wound Healing: Case Reports
Torsiello Michael J
, Kopacki Matthew H
Sep/Oct 2000
Pg. 356

View Sample
Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream
Allen Loyd V Jr
Jul/Aug 2020
Pg. 313

Ketamine for Pain in Hospice Patients - A Transdermal Gel Applied to the Painful Site
Wood Robert M
Jul/Aug 2024
Pg. 278-281

Silver Sulfadiazine 1% and Hydrocortisone 2% Gel
Allen Loyd V Jr
Sep/Oct 2023
Pg. 422-423

A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
Nov/Dec 2022
Pg. 480-488

Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays
Allen Loyd V Jr
Jan/Feb 2023
Pg. 30-37

Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product
Chauhan Nikita N
, Patel Jayvadan K
Jan/Feb 2023
Pg. 60-71

Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base
Spennacchio Antonio
, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Jan/Feb 2023
Pg. 72-77

Nystatin, Lidocaine, Hydrocortisone, and Chlorhexidine Oral Rinse
Allen Loyd V Jr
Mar/Apr 2023
Pg. 148

Psoriasis Topical Ointment
Allen Loyd V Jr
Jul/Aug 2022
Pg. 329

Mesalamine 100-mg/mL Suspension Enema
Allen Loyd V Jr
Mar/Apr 2022
Pg. 144

Naproxen 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 145

Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2
Riepl Mike
Jul/Aug 2021
Pg. 282-287

Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 416

Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion
Allen Loyd V Jr
Jul/Aug 2022
Pg. 318

Dexamethasone 1 mg/mL in Oral Mix
Allen Loyd V Jr
Jul/Aug 2022
Pg. 320

Indomethacin 1% Topical Gel
Allen Loyd V Jr
Jul/Aug 2022
Pg. 325-326

Nystatin 250,000-unit Frozen Popsicles
Allen Loyd V Jr
Jul/Aug 2022
Pg. 327

A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Riepl Mike
Jul/Aug 2022
Pg. 270-274

Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 491

Flunisolide Nasal Spray
Allen Loyd V Jr
May/Jun 2019
Pg. 233

Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients
de Lafuente Yanina
, García Mónica Cristina, Jiminez-Kairuz Alvaro
Jul/Aug 2019
Pg. 324-331

Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report
Pope George
, Daleo Charles, Batson SL
Sep/Oct 2019
Pg. 358-364

Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment
Allen Loyd V Jr
Jan/Feb 2020
Pg. 57

LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment
Allen Loyd V Jr
Jan/Feb 2020
Pg. 59

Prednisone 5 mg/mL ir Oral Mix Suspension
Allen Loyd V Jr
Nov/Dec 2018
Pg. 497

Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment
Allen Loyd V Jr
Sep/Oct 2022
Pg. 430

The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet
Alhmoud Hassan
, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani
Sep/Oct 2023
Pg. 431-439

Highlighting the Benefits of AlpaWash in Wound Care: Case Reports in Small Animals
Semighini Flavia
, Fornaciari Lais de Azevedo, Pinheiro Vanessa, Lupatini Rodrigo, Haiub Halema, Cull Erica, Sidhu Raman
Nov/Dec 2023
Pg. 454-460

Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management
Rodriguez Franklin
, Carvalho Maria, Banov Fabiana
Nov/Dec 2023
Pg. 468-473

Curcumin 1% Intranasal Mucoadhesive Gel
Allen Loyd V Jr
Nov/Dec 2023
Pg. 490

Dexamethasone 1 mg/mL in Oral Mix SF
Allen Loyd V Jr
Jul/Aug 2023
Pg. 322

Acetaminophen 500-mg/mL Rectal Solution
Allen Loyd V Jr
May/Jun 2023
Pg. 232-233

Case Report in Equine: Highlighting the Benefits of Medisca CopaSil in Burn Scar Management
Heuerman Jason
, Haiub Halema, Cull Erica, Lupatini Rodrigo, Shrum Brandon, Sidhu Raman
Jul/Aug 2023
Pg. 270-276

Magic Mouthwashes- A Literature Review and Discussion of Common Compositions
McElhiney Linda F
Mar/Apr 2024
Pg. 94-98

Diclofenac Sodium 1% Soft-patch Gel
Allen Loyd V Jr
Mar/Apr 2024
Pg. 134

Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Allen Loyd V Jr
Mar/Apr 2024
Pg. 136

Drug Therapy for Acute and Chronic Pain in the Cat
Lascelles B Duncan
Sep/Oct 2002
Pg. 338-343

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Indomethacin 50-mg Suppositories
Allen Loyd V Jr
Sep/Oct 2003
Pg. 375

Pentazocine HCl 12.5-mg and Aspirin 325-mg Capsules
Allen Loyd V Jr
Sep/Oct 2003
Pg. 377

Phenylbutazone 100-mg Capsules
Allen Loyd V Jr
Sep/Oct 2003
Pg. 379

Dipyrone 500-mg/mL Injection, Veterinary
Allen Loyd V Jr
May/Jun 2005
Pg. 227

Meloxicam 0.2 mg/mL Oral Liquid, Veterinary
Allen Loyd V Jr
May/Jun 2005
Pg. 228

Piroxicam 2-mg/mL Oral Liquid, Veterinary
Allen Loyd V Jr
May/Jun 2005
Pg. 234

Naproxen Sodium 100-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2005
Pg. 68

Clobetasol Topical Spray
Allen Loyd V Jr
Mar/Apr 2005
Pg. 149

Silver Sulfadiazine 1% and Fluriprofen 2% Cream
Allen Loyd V Jr
Mar/Apr 2005
Pg. 155

Dexamethasone and Furosemide Injection
Allen Loyd V Jr
Jul/Aug 2009
Pg. 335

An Abridged History of Aspirin
Vance Dwight A
Sep/Oct 2009
Pg. 404-409

Ketoprofen 100-mg/5-mL Mouth Rinse
Allen Loyd V Jr
Jan/Feb 2010
Pg. 68

Ketoprofen 20% Topical Solution
Allen Loyd V Jr
Sep/Oct 2008
Pg. 452

Piroxicam 5% and Dexpanthenol 5% Gel
Allen Loyd V Jr
Sep/Oct 2008
Pg. 454

Aceclofenac 1.5% Gel-Cream
Allen Loyd V Jr
Sep/Oct 2008
Pg. 446

A Review of Stomatitis and Treatment in Cats
Ray Jody D
, Jordan Dinah G, Eubanks Diana L, Crosswhite Megan E
Sep/Oct 2009
Pg. 372-381

Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Williams LaVonn A
, Fokken Dawn
Sep/Oct 2009
Pg. 386-389

Diclofenac Sodium 1% Soft-Patch Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 65

Diclofenac Sodium 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 66

Flosulide 10-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2008
Pg. 69

Piroxicam 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 71

Piroxicam 1% Soft-Patch Topical Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 72

Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches
Williams Steve D
Sep/Oct 2006
Pg. 351

Diclofenac Sodium 75-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2007
Pg. 421

Meloxicam 0.3% Topical Gel
Allen Loyd V Jr
May/Jun 2008
Pg. 264

Dexamethasone 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 72

Prednisone 10-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 77

Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 78

Chemical Stability of Diclofenac Sodium Injection
Gupta Vishnu D
Mar/Apr 2006
Pg. 154-155

Indomethacin 2-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 458

Aspirin 80-mg/5-mL Oral Liquid, Anhydrous
Allen Loyd V Jr
Mar/Apr 2007
Pg. 154

The Rectal Rocket: A Two-Day Treatment for Hemorrhoids
Vail Jane
May/Jun 2007
Pg. 194-199

Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain
Fields Shannon W
May/Jun 2007
Pg. 200

Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E
, Carvalho Maria, Phan Ha, Tuma Cristiane
Jan/Feb 2017
Pg. 22-27

Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Allen Loyd V Jr
May/Jun 2017
Pg. 234

Meloxicam 1% Topical Gel
Allen Loyd V Jr
May/Jun 2017
Pg. 235

Tolmetin 400-mg Capsules
Allen Loyd V Jr
Nov/Dec 2017
Pg. 497

Pain: Systematic Review of Pharmacy Compounding of Pain Medication
Shawaqfeh Mohammad S
, Harrington Catherine
Jan/Feb 2018
Pg. 19-24

Basics of Compounding: Providing Pharmacy Services to Bariatric Surgery Patients
McElhiney Linda F
Jan/Feb 2018
Pg. 30-39

Naproxen 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
Jan/Feb 2018
Pg. 54

Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension
Manchanda Arushi
, Laracy Melissa, Savji Taslim, Bogner Robin H
Jan/Feb 2018
Pg. 66-75

Evaluation and Comparison of Wound Healing Properties of an Ointment (AlpaWash) Containing Brazilian Micronized Propolis and Peucedanum ostruthium Leaf Extract in Skin Ulcer in Rats
Nani Marcel
, Leone Andréia, Bom Vinícius Pedro, Buszinski Andrei Felipe, Oliveira de Souza Rebeca, Pinheiro Vanessa Alves, Danapoulos Panagiota, Swikidisa Rosita, Marquele-Oliveira Franciane, Cipriani Frade Marco Andrey, Berretta Andresa Aparecida, Nogueira Rodrigo José Lupatini
Mar/Apr 2018
Pg. 154-163

Budesonide 1-mg//10-mL Mucolox Oral Suspensions
Allen Loyd V Jr
Jul/Aug 2018
Pg. 317

Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory
, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Sep/Oct 2015
Pg. 357-365

Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel
Allen Loyd V Jr
Sep/Oct 2015
Pg. 405

Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations
Lupatini Nogueira Rodrigo José
, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa
Jul/Aug 2016
Pg. 333-337

Naproxen 5% Cream
Allen Loyd V Jr
Sep/Oct 2016
Pg. 410

Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Polonini HC
, Loures S, Lima LC, Ferreira AO, Brandão MA
Mar/Apr 2016
Pg. 167-174

Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment
Allen Loyd V Jr
May/Jun 2016
Pg. 228

Indomethacin Gel
Allen Loyd V Jr
May/Jun 2016
Pg. 230

Pain-Away II Headache Capsules
Allen Loyd V Jr
May/Jun 2016
Pg. 233

Choline Magnesium Trisalicylate Liquid
Allen Loyd V Jr
Jul/Aug 2014
Pg. 327

Magic Mouthwashes: A Literature Review and Discussion of Common Compositions
McElhiney Linda F
Sep/Oct 2011
Pg. 376-380

Hydrocortisone 100-mg/60-mL Retention Enema
Allen Loyd V Jr
Jul/Aug 2011
Pg. 338

Treating Inner Ear Disorders with Intratympanic Drug Administration
McElhiney Linda F
Jul/Aug 2011
Pg. 302-307

Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
May/Jun 2011
Pg. 245

Treatment Options for Psoriasis
Williams LaVonn A
, Humphreys Erica
May/Jun 2011
Pg. 204-213

Diclofenac Sodium 1% Topical Gel
Allen Loyd V Jr
May/Jun 2011
Pg. 243

Ibuprofen 5% Topical Cream
Allen Loyd V Jr
May/Jun 2011
Pg. 244

Flurbiprofen 5% Bioadhesive Gel for Gingivitis
Allen Loyd V Jr
Jul/Aug 2010
Pg. 341

Alpha-Bisabolol Mouthwash
Allen Loyd V Jr
Sep/Oct 2010
Pg. 420

Diclofenac Sodium 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2011
Pg. 64

Ibuprofen 5% Gel
Allen Loyd V Jr
Jan/Feb 2011
Pg. 66

Piroxicam 1% Gel
Allen Loyd V Jr
Jan/Feb 2011
Pg. 69

Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 512

Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 513

Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 514

Ketoprofen 2% Oral Gel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 521

"My Hip Hurts": A Collaboration of Clinicians in the Treatment of Adhesive Capsulitis to Optimize Patient Care
Cox Chris
Nov/Dec 2010
Pg. 480-483

Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 520

Betamethasone 0.6-mg/5-mL Syrup
Allen Loyd V Jr
Jul/Aug 2012
Pg. 332

Ketorolac Tromethamine 15-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 337

Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies
Zur Eyal
Sep/Oct 2012
Pg. 386-393

Prednisone 10-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 236

Carprofen 2.5-mg/mL Oral Suspension, Veterinary
Allen Loyd V Jr
May/Jun 2010
Pg. 241

Ibuprofen 10-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 67

Basics of Compounding: Basics of Compounding with Tars
Allen Loyd V Jr
Sep/Oct 2013
Pg. 400-410

Indomethacin 1-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 419

Methotrexate 25-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 421

Cortisone Acetate 25-mg Capsules
Allen Loyd V Jr
Nov/Dec 2013
Pg. 501

Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Klemmer Anja
, Krämer Irene, Kamin Wolfgang
May/Jun 2013
Pg. 254-261

Methotrexate 2.5-mg Capsules
Allen Loyd V Jr
May/Jun 2014
Pg. 238

Naproxen 25-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2014
Pg. 239

Investigation of Physical and Chemical Stability of an Ointment with Herbals
Zdoryk Oleksandr A
, Khokhlova Kateryna O, Georgiyants Victoriya A, Vyshnevska Liliia I
May/Jun 2014
Pg. 248-252

Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview
Allen Loyd V Jr
Sep/Oct 2022
Pg. 400-408

Curcumin 2% Topical Gel
Allen Loyd V Jr
Nov/Dec 2022
Pg. 509

Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Riepl Mike
Sep/Oct 2021
Pg. 372-377

Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis
Song Guiyun
, Ip Kendice, Shan Ashley, Banov Daniel, Bassani August S
Jul/Aug 2020
Pg. 337-345

Hydrocortisone 2% in Versapro Cream
Allen Loyd V Jr
Sep/Oct 2023
Pg. 416

Rice Bran Oil: Preparation and Evaluation of Novel Liquisolid and Semisolid Formulations
Ammar Hussein O
, Al-Okbi Sahar Y, Mostafa Dina M, Helal Amr M
Nov/Dec 2012
Pg. 516-523

Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Polonini Hudson C
, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
Jul/Aug 2014
Pg. 332-340

Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations
Bryson Evan
, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
Mar/Apr 2015
Pg. 161-166

Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott
, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010
Pg. 182-192

Innovative Uses of Compounded Tranilast: An Interview with Compounding Pharmacist Larry J. Frieders, RPh
Vail Jane
Mar/Apr 2007
Pg. 132-135

Fibromyalgia
Oberlander Kevin
Jan/Feb 2000
Pg. 21-23

Disopyramide 100-mg Capsules
Allen Loyd V Jr
Jul/Aug 2017
Pg. 315

Reserpine 0.5-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 237

Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Logomasini Mark A
, Stout Richard R, Ron Marcinkoski
Jul/Aug 2013
Pg. 270-280

Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Zur Eyal
Nov/Dec 2011
Pg. 458-463

Topical Treatment of Primary Focal Hyperhidrosis, Part 1
Zur Eyal
Jan/Feb 2019
Pg. 23-31

Chemical Stability of Desonide in Ear Drops
Gupta Vishnu D
Jan/Feb 2007
Pg. 79-81

ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient
Moon Richard B
Mar/Apr 2006
Pg. 95-98

Probiotic Therapy, Part 1: Beneficial Bacteria Improve Health, Save Lives
Vail Jane
Mar/Apr 2006
Pg. 107-111

Probiotic Therapy, Part 2: Clinical Perspectives
Vail Jane
May/Jun 2006
Pg. 195-200

Betamethasone Valerate 0.1% Topical Gel
Allen Loyd V Jr
Sep/Oct 2007
Pg. 419

Miconazole Nitrate 2%, Deoxy-D-Glucose 0.2%, and Hydrocortisone 0.4% Lip Balm
Allen Loyd V Jr
May/Jun 2008
Pg. 265

Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model
Bassani August S
, Banov Daniel, Lehman Paul A
May/Jun 2008
Pg. 270-273

Tretinoin and (-)Alpha-Bisabolol Gel
Allen Loyd V Jr
Jul/Aug 2008
Pg. 360

Tretinoin and Dexpanthenol Gel
Allen Loyd V Jr
Jul/Aug 2008
Pg. 361

African Scalp Lotion
Allen Loyd V Jr
May/Jun 2008
Pg. 260

Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
May/Jun 2010
Pg. 200-203

Tetracaine 4% and Menthol 5% Topical Gel
Allen Loyd V Jr
Jan/Feb 2010
Pg. 73

Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Bramwell Bethany L
Mar/Apr 2010
Pg. 108-111

Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Ploesser Jennifer
, Weinstock Leonard B, Thomas Erin
Mar/Apr 2010
Pg. 171-173

Lubow's Solution
Allen Loyd V Jr
Nov/Dec 2009
Pg. 558

Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms
Bramwell Bethany L
Nov/Dec 2009
Pg. 498-505

Recommended Tips for Treating Veterinary Patients
Bramwell Bethany L
, Williams LaVonn A
Sep/Oct 2009
Pg. 390-391

Safe Use of Topical Local Anesthetic Medications for Pain Management
Epshteyn Mikhail G
, Pepin Steven M
May/Jun 2009
Pg. 218-219

Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report
Muller George
May/Jun 2009
Pg. 220-221

Hormone Treatment Options for Males: What to Do for Men with Low Testosterone
Biundo Bruce
Jul/Aug 2009
Pg. 276-279

Alcohol-based Carbomer Gel
Allen Loyd V Jr
Jul/Aug 2009
Pg. 332

Dextromethorphan Hydrobromide 10% and Guaifenesin 10% Rapidly Penetrating Gel
Allen Loyd V Jr
Jan/Feb 2009
Pg. 66

Diaper Rash Cream with Miconazole
Allen Loyd V Jr
Jan/Feb 2009
Pg. 68

Testing of Estradiol in a Compounded Cream and a Stock Solution
Buderer Matthew J
, Buderer Nancy M
Jan/Feb 2009
Pg. 74-77

Ketamine for Pain in Hospice Patients
Wood Robert M
Jul/Aug 2000
Pg. 253-254

Calculations
Prince Shelly J
Jul/Aug 2002
Pg. 305

Interview: Katharina Dalton, MD: Progesterone and Related Topics
Allen Loyd V Jr
Sep/Oct 1999
Pg. 332-339

Update on Transdermals for Animal Patients
Davidson Gigi S
May/Jun 2005
Pg. 178-182

View Sample
Diclofenac Sodium 25-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2004
Pg. 470

Case Report: Diagnosis and Management of Trigeminal Neuralgia and Chronic Paroxysmal Hemicrania in a 43-Year-Old Woman – Oral and Transmucosal Pharmacologic Medications
Heir Gary M
, Covalesky Bernard, Karolchyk Scott
Sep/Oct 2004
Pg. 337-343

Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study
Glisson James K
, Wood Rebecca L, Kyle Patrick B, Cleary John D
May/Jun 2005
Pg. 242-246

Mercaptopurine 50-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2006
Pg. 64

The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP
Allen Loyd V Jr
May/Jun 2003
Pg. 180-183

A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Gillson George R
, Zava David T
Jul/Aug 2003
Pg. 250-256

Calculations
Prince Shelly J
Jul/Aug 2003
Pg. 294

Thioguanine 20-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2011
Pg. 506

Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient
McElhiney Linda F
Sep/Oct 2011
Pg. 386-387

Cromolyn Sodium 50-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2011
Pg. 336

Tea Tree Oil Acne Gel
Allen Loyd V Jr
Mar/Apr 2011
Pg. 165

Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date
Pignato Alyssa
, Pankaskie Marvin, Birnie Christine
Nov/Dec 2010
Pg. 522-525

Calculations
Stockton Shelly J
Jan/Feb 2011
Pg. 62

Icy Blue Camphorated Gel
Allen Loyd V Jr
Sep/Oct 2010
Pg. 422

Considerations for Percutaneous Absorption
Newton Stephen J
, Cook Jennifer M
Jul/Aug 2010
Pg. 301-304

Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser
Christiansen Joel
, White Lyndell
Jul/Aug 2010
Pg. 310-314

Potential Treatments for Radiation Dermatitis
Corsini Lindsay
May/Jun 2010
Pg. 210-213

Calculations
Stockton Shelly J
May/Jun 2010
Pg. 230

Basics of Compounding: Foam Dosage Forms
Allen Loyd V Jr
Jul/Aug 2013
Pg. 312-322

Chemical Penetration Enhancers
Newton Stephen J
Sep/Oct 2013
Pg. 370-374

Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F
, Sauvageot Jurgita
May/Jun 2014
Pg. 253-255

Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream
Wang Xuexuan
, Black Laura
Nov/Dec 2013
Pg. 520-525

Calculations
Stockton Shelly J
Jan/Feb 2014
Pg. 58-59

The Standardization of Nonsterile Compounding: A Study in Quality Control and Assessment for Hormone Compounding
Wiley TS
, Odegard RD, Raden J, Haraldsen JT
Mar/Apr 2014
Pg. 162-168

Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice
McNulty John P
, Muller George
May/Jun 2014
Pg. 190-200

Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams
Allen Loyd V Jr
May/Jun 2014
Pg. 228-230

Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities
Zur Eyal
Mar/Apr 2013
Pg. 113-123

Mercaptopurine 75-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 234

Treatment Options for Male Hypogonadism
Biundo Bruce
Jan/Feb 2013
Pg. 28-38

Calculations
Stockton Shelly J
Sep/Oct 2012
Pg. 416

Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date
Peacock Gina F
, Sauvageot Jurgita
Sep/Oct 2012
Pg. 428-430

Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Choo Winnie
Jul/Aug 2017
Pg. 282-289

Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives
Trimble John O
, Light Bob
Nov/Dec 2017
Pg. 530-535

Basics of Compounding: Clinical Pharmaceutics, Part 2
Allen Loyd V Jr
Nov/Dec 2016
Pg. 485-493

Infliximab 1% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2017
Pg. 62

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1
Allen Loyd V Jr
Mar/Apr 2017
Pg. 127-130

Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs
Gorman Gregory
, Sokom Simara, Coward Lori, Arnold John J
Mar/Apr 2017
Pg. 164-170

Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Jul/Aug 2018
Pg. 319

Minoxidil 50 mg/mL in Espumil Foam Base
Allen Loyd V Jr
Jul/Aug 2018
Pg. 322

Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
Sep/Oct 2018
Pg. 409

Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications
Zur Eyal
Nov/Dec 2018
Pg. 446-454

Case Study: Absorption of Testosterone Cream via Scrotal Delivery
Needham Shawn
, Needham Shane
Nov/Dec 2018
Pg. 466-468

Anhydrous Silicon Base Topical Gel Vehicle
Allen Loyd V Jr
May/Jun 2018
Pg. 232

The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1
Williams LaVonn
Jul/Aug 2018
Pg. 284-287

Anhydrous Medium-chain Triglycerides Gel
Allen Loyd V Jr
Jul/Aug 2018
Pg. 316

Basics of Compounding: Compounding Microemulsions
Allen Loyd V Jr
Mar/Apr 2018
Pg. 137-143

Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
Jan/Feb 2018
Pg. 51

Basics of Compounding: Compounding with Silicones
Allen Loyd V Jr
May/Jun 2015
Pg. 223-230

Skin Penetration and Antinociception of Topical Gabapentin Formulations
Bryson Evan
, Asbill Scott, Sweitzer Sarah
Nov/Dec 2014
Pg. 504-511

In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Heustess Allie
, Asbill Scott, Eagerton David, Arnold John
Nov/Dec 2014
Pg. 512-515

Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jan/Feb 2015
Pg. 6-12

Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F
, Sauvageot Jurgita
Jul/Aug 2014
Pg. 345-347

Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F
, Sauvageot Jurgita, Addo Richard T
Jul/Aug 2014
Pg. 348-350

Calculations
Stockton Shelly J
Jul/Aug 2014
Pg. 320-321

Progesterone 10% Cream
Allen Loyd V Jr
Sep/Oct 2016
Pg. 412

Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Allen Loyd V Jr
Nov/Dec 2015
Pg. 508

Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Choo Winnie
Jan/Feb 2016
Pg. 6-10

Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin
Le Uyen Minh
, Baltzley Sarah, AlGhananeem Abeer
Nov/Dec 2018
Pg. 498-503

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1
Zur Eyal
May/Jun 2019
Pg. 200-207

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants
Allen Loyd V Jr
Sep/Oct 2020
Pg. 388-395

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 8: Humectants
Allen Loyd V Jr
Mar/Apr 2021
Pg. 126-128

NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
Nov/Dec 2020
Pg. 446-448

Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing
Teimouri Arezou
, Yeung Pollen, Agu Remigius U
Nov/Dec 2020
Pg. 501-508

Calculations
Stockton Shelly J
Mar/Apr 2020
Pg. 128

Feasibility Study of Asthma Cream
Kuang Andrew
Mar/Apr 2020
Pg. 163-167

Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Dahal Amit
, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Mar/Apr 2020
Pg. 168-175

Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base
Polonini Hudson C
, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
Jul/Aug 2021
Pg. 336-343

A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide
Riepl Mike
May/Jun 2022
Pg. 189-193

A Compendium of Compounding Agents and Formulations, Part 1: Melatonin
Riepl Mike
Jan/Feb 2022
Pg. 18-23

Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin
Riepl Mike
Nov/Dec 2021
Pg. 468-472

Compounding for the Treatment of COVID-19 and Long COVID, Part 1: Terminology, Mutations, and Variants
Riepl Mike
Jan/Feb 2023
Pg. 12-21

Calculations
Stockton Shelly J
Sep/Oct 2022
Pg. 420

Compounding for the Treatment of COVID-19 and Long COVID, Part 3: The Role of Toll-like Receptors in SARS-CoV-2 Infection and COVID Development
Riepl Mike
, Kaiser Joe
May/Jun 2023
Pg. 192-200

Nonsterile Basics of Compounding: Compounding with Humectants
Allen Loyd V Jr
May/Jun 2023
Pg. 218-221

PreScription: A New Dosage Form
Allen Loyd V Jr
Sep/Oct 2022
Pg. 356

A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
Sep/Oct 2022
Pg. 364-368

Compounded Medications and Probiotics for Irritable Bowel Syndrome
Narváez Katherine Rivera
, Thompson Tara
Sep/Oct 2022
Pg. 378-384

Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods
Allen Loyd V Jr
Nov/Dec 2022
Pg. 490-495

Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion
Allen Loyd V Jr
Nov/Dec 2022
Pg. 508

Idoxuridine 5% in Dimethyl Sulfoxide
Allen Loyd V Jr
Sep/Oct 2023
Pg. 417

Compounding Metformin for Use in Functional Medicine
Desai Sarina
, Thompson Tara
Sep/Oct 2023
Pg. 362-366

Treatment Options for Male Hypogonadism
Biundo Bruce
Jan/Feb 2024
Pg. 6-14

Hormone Treatment Options for Males: What to do for Men with Low Testosterone
Biundo Bruce
Jan/Feb 2024
Pg. 28-32

Safe Use of Topical Local Anesthetic Medications for Pain Management
Epshteyn Mikhail G
, Pepin Steven M
Mar/Apr 2024
Pg. 118-119

Sulfadiazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2021
Pg. 508

Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
Jul/Aug 2022
Pg. 328

Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions
Wilder Alyson G
, Foushee Jaime A, Fox Laura M, Navalle Jordan, Wright Adrienne M, Greer Megan A
May/Jun 2020
Pg. 238-241

Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2020
Pg. 407

Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2020
Pg. 60

Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution
Marotta James C
, Patel Gopesh, Carvalho Maria, Blakeney Samantha
Jan/Feb 2020
Pg. 69-76

Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored
Allen Loyd V Jr
Jan/Feb 2020
Pg. 54

Povidone Iodine 10% Cold Sore Paint
Allen Loyd V Jr
Sep/Oct 2015
Pg. 409

Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy
Karara Adel H
, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
Nov/Dec 2016
Pg. 461-467

Chloramphenicol 100-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 325

Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary
Allen Loyd V Jr
Sep/Oct 2018
Pg. 410

Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Jul/Aug 2018
Pg. 325

Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Jul/Aug 2018
Pg. 320

Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4
de Oliveira Ferreira Anderson
, Polonini Hudson, Loures da Silva Sharlene, Buzinari Aglio Natália Cristina, Abreu Jordana, Fernandes Brandão Marcos Antônio
Jul/Aug 2017
Pg. 339-346

Bacitracin 500-U/g Ophthalmic Ointment
Allen Loyd V Jr
Nov/Dec 2003
Pg. 467

Meclocycline Sulfosalicylate 1% Cream
Allen Loyd V Jr
Nov/Dec 2003
Pg. 471

Ambulatory Pumps: Part I of a Three-Part Series - Peristaltic Infusion Devices Review
Ashworth Lisa D
Jul/Aug 2000
Pg. 281-285

Metronidazole in Normal Saline Enema
Allen Loyd V Jr
Jan/Feb 2010
Pg. 69

Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder
Allen Loyd V Jr
Jul/Aug 2008
Pg. 355

Compounding for the Complications of Diabetes: Interviews with Compounding Pharmacists George B. Muller, RPh, and Jerrod Roberts, DPh
Vail Jane
Mar/Apr 2007
Pg. 106-110

Return to Top